Skip to main content
Clinical Trials/DRKS00028789
DRKS00028789
Completed
Not Applicable

Retrospective, mono-centric post-market clinical follow-up study on the use of Cerasorb® Foam for socket preservation in dental surgery - ReSORB

curasan AG0 sites54 target enrollmentMay 9, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
curasan AG
Enrollment
54
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2022
End Date
May 27, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
curasan AG

Eligibility Criteria

Inclusion Criteria

  • Patients who have been treated according to the intended use and instructions for use of Cerasorb Foam and have undergone dental surgery for filling and reconstruction of two\-walled and multi\-walled non\-infected bone, with existing documentation for:
  • \- diagnosis of tooth not worthy of preservation
  • \- surgical treatment of tooth extraction, including digital volume tomography (DVT) measurement of dental alveolus according to AWMF guidelines 083\-005 and 083\-011
  • \- removal of stitches (safety visit)
  • \- implant placement with prior DVT follow\-up measurement of dental alveolus

Exclusion Criteria

  • Patients whose diagnosis does not fall within the indications, or whose medical condition is one of the contraindications for Cerasorb Foam, which are:
  • \- Acute and chronic infections in the operative field
  • \- Severe metabolic disorders, such as severe, uncontrolled, or poorly controlled diabetes or bone diseases which impair bone or wound healing
  • \- Disorders of calcium metabolism \- Steroid treatment \- Drugs that interfere with calcium metabolism
  • \- Immunosuppressive therapy
  • \- Endocrine bone disease
  • \- Radiation therapy
  • \- Nicotine abuse
  • \- Known allergies to porcine collagen or other protein allergies.

Outcomes

Primary Outcomes

Not specified

Similar Trials